21 CFR 520.170

§ 520.170 Bexagliflozin.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.170, § 520.170 Bexagliflozin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87089
Permanent ID: ys:prov:87089@1
SHA-256: 01d699bee6db98bfcb38f2cf31deb6956dc38f331766b00f462d71826ffb8c67

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains 15 milligrams bexagliflozin. (b) Sponsor. See No. 058198 in § 510.600(c) of this chapter. (c) Conditions of use—(1) Amount. Administer one tablet by mouth to cats 6.6 lb (3.0 kg) or greater once daily, at approximately the same time each day, with or without food, and regardless of blood glucose level. (2) Indications for use. To improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.